|
gptkbp:instanceOf
|
corporate defense mechanism
|
|
gptkbp:adoptedBy
|
gptkb:Board_of_Trustees
|
|
gptkbp:alsoKnownAs
|
poison pill
|
|
gptkbp:canBe
|
flip-in plan
flip-over plan
|
|
gptkbp:canBeTerminatedBy
|
gptkb:Board_of_Trustees
|
|
gptkbp:commonIn
|
21st century
1980s and 1990s
|
|
gptkbp:criticizedFor
|
entrenching management
|
|
gptkbp:effect
|
dilutes shares of hostile acquirer
|
|
gptkbp:firstCompanyToUse
|
Wachtell, Lipton, Rosen & Katz (legal firm for first plan)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Shareholder Rights Plan
|
|
gptkbp:introducedIn
|
1982
|
|
gptkbp:mayInclude
|
rights to buy additional shares at discount
|
|
gptkbp:originatedIn
|
gptkb:United_States
|
|
gptkbp:purpose
|
prevent hostile takeovers
|
|
gptkbp:regulates
|
gptkb:Securities_and_Exchange_Commission_(SEC)
|
|
gptkbp:requires
|
shareholder approval in some jurisdictions
|
|
gptkbp:subject
|
legal challenges
|
|
gptkbp:supportedBy
|
companies seeking to deter takeovers
|
|
gptkbp:triggeredBy
|
acquisition of certain percentage of shares
|
|
gptkbp:usedBy
|
public companies
|
|
gptkbp:bfsParent
|
gptkb:Martin_Lipton
gptkb:Tender_Offer
|
|
gptkbp:bfsLayer
|
7
|